» Articles » PMID: 12086891

A Role for Common Fragile Site Induction in Amplification of Human Oncogenes

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2002 Jun 28
PMID 12086891
Citations 114
Authors
Affiliations
Soon will be listed here.
Abstract

Oncogene amplification is an important process in human tumorigenesis, but its underlying mechanism is currently unknown. Cytogenetic analysis indicates that amplification of drug-selected genes in rodent cells is driven by recurrent breaks within chromosomal common fragile sites (CFSs), via the breakage-fusion-bridge (BFB) mechanism. Here we show that BFB cycles drive the intrachromosomal amplification of the MET oncogene in a human gastric carcinoma. Our molecular evidence includes a "ladder-like" structure and inverted repeat organization of the MET amplicons. Furthermore, we show that the breakpoints, setting the centromeric amplicon boundaries, are within the CFS FRA7G region. Upon replication stress, this region showed perturbed chromatin organization, predisposing it to breakage. Thus, in vivo induction of CFSs can play an important role in human oncogenesis.

Citing Articles

Research progress on the role of bypass activation mechanisms in resistance to tyrosine kinase inhibitors in non-small cell lung cancer.

Jiang Z, Gu Z, Yu X, Cheng T, Liu B Front Oncol. 2024; 14:1447678.

PMID: 39582541 PMC: 11581962. DOI: 10.3389/fonc.2024.1447678.


From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies.

Gharib E, Robichaud G Int J Mol Sci. 2024; 25(17).

PMID: 39273409 PMC: 11395697. DOI: 10.3390/ijms25179463.


Mechanical stress during confined migration causes aberrant mitoses and c-MYC amplification.

Bastianello G, Kidiyoor G, Lowndes C, Li Q, Bonnal R, Godwin J Proc Natl Acad Sci U S A. 2024; 121(29):e2404551121.

PMID: 38990945 PMC: 11260125. DOI: 10.1073/pnas.2404551121.


Evaluation of the gene fusion landscape in early onset sporadic rectal cancer reveals association with chromatin architecture and genome stability.

Gupta A, Avadhanula S, Bashyam M Oncogene. 2024; 43(32):2449-2462.

PMID: 38937601 DOI: 10.1038/s41388-024-03088-z.


The MET Oncogene: Thirty Years of Insights into Molecular Mechanisms Driving Malignancy.

Crepaldi T, Gallo S, Comoglio P Pharmaceuticals (Basel). 2024; 17(4).

PMID: 38675409 PMC: 11054789. DOI: 10.3390/ph17040448.